PDE5A and Alzheimer disease: Specifically, a rat model of AD treated with a PDE5 inhibitor showed increases in vascular endothelial growth factor A and cyclic GMP, decreases in vascular cell adhesion molecule 1 and tumor necrosis factor alpha, and increased memory performance compared to the non-treated group [119].